Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H B Feys

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Vox Sanguinis|May 26, 2018
Comparison of three commercially available buffy coat pooling sets for the preparation of platelet concentratesH B Feys, R Devloo, B Sabot, et al.
Vox Sanguinis|December 10, 2015
The contribution of von Willebrand factor-GPIbα interactions to persistent aggregate formation in apheresis platelet concentratesH B Feys, B Van Aelst, R Devloo, et al.
Vox Sanguinis|August 11, 2016
Persistent aggregates in apheresis platelet concentrates are commonly collected from donors with a history of aggregate donationH B Feys, H Pottel, J Coene, et al.
Vox Sanguinis|January 6, 2015
Riboflavin and amotosalen photochemical treatments of platelet concentrates reduce thrombus formation kinetics in vitroB Van Aelst, H B Feys, R Devloo, et al.
Vox Sanguinis|September 30, 2017
High platelet content can increase storage lesion rates following Intercept pathogen inactivation primarily in platelet concentrates prepared by apheresisH B Feys, R Devloo, B Sabot, et al.
Journal of Thrombosis and Haemostasis : JTH|September 22, 2009
Multi-step binding of ADAMTS-13 to von Willebrand factorH B Feys, P J Anderson, K Vanhoorelbeke, et al.
Vox Sanguinis|March 11, 2015
Persistent aggregates in apheresis platelet concentratesH B Feys, J Coene, R Devloo, et al.
Vox Sanguinis|January 28, 2014
Oxygen removal during pathogen inactivation with riboflavin and UV light preserves protein function in plasma for transfusionH B Feys, B Van Aelst, K Devreese, et al.
Journal of Thrombosis and Haemostasis : JTH|June 18, 2010
Inactivation of ADAMTS13 by plasmin as a potential cause of thrombotic thrombocytopenic purpuraH B Feys, N Vandeputte, R Palla, et al.
Journal of Thrombosis and Haemostasis : JTH|August 11, 2010
The distal carboxyterminal domains of murine ADAMTS13 influence proteolysis of platelet-decorated VWF strings in vivoB De Maeyer, S F De Meyer, H B Feys, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Vox Sanguinis|May 26, 2018
Comparison of three commercially available buffy coat pooling sets for the preparation of platelet concentratesH B Feys, R Devloo, B Sabot, et al.
Vox Sanguinis|December 10, 2015
The contribution of von Willebrand factor-GPIbα interactions to persistent aggregate formation in apheresis platelet concentratesH B Feys, B Van Aelst, R Devloo, et al.
Vox Sanguinis|August 11, 2016
Persistent aggregates in apheresis platelet concentrates are commonly collected from donors with a history of aggregate donationH B Feys, H Pottel, J Coene, et al.
Vox Sanguinis|January 6, 2015
Riboflavin and amotosalen photochemical treatments of platelet concentrates reduce thrombus formation kinetics in vitroB Van Aelst, H B Feys, R Devloo, et al.
Vox Sanguinis|September 30, 2017
High platelet content can increase storage lesion rates following Intercept pathogen inactivation primarily in platelet concentrates prepared by apheresisH B Feys, R Devloo, B Sabot, et al.
Journal of Thrombosis and Haemostasis : JTH|September 22, 2009
Multi-step binding of ADAMTS-13 to von Willebrand factorH B Feys, P J Anderson, K Vanhoorelbeke, et al.
Vox Sanguinis|March 11, 2015
Persistent aggregates in apheresis platelet concentratesH B Feys, J Coene, R Devloo, et al.
Vox Sanguinis|January 28, 2014
Oxygen removal during pathogen inactivation with riboflavin and UV light preserves protein function in plasma for transfusionH B Feys, B Van Aelst, K Devreese, et al.
Journal of Thrombosis and Haemostasis : JTH|June 18, 2010
Inactivation of ADAMTS13 by plasmin as a potential cause of thrombotic thrombocytopenic purpuraH B Feys, N Vandeputte, R Palla, et al.
Journal of Thrombosis and Haemostasis : JTH|August 11, 2010
The distal carboxyterminal domains of murine ADAMTS13 influence proteolysis of platelet-decorated VWF strings in vivoB De Maeyer, S F De Meyer, H B Feys, et al.
Pageof 2